Publications by authors named "Yasui W"

Gastric cancer (GC) is the third leading cause of cancer-related deaths in Japan, underscoring the urgent need for deeper insights into its pathogenesis. Spheroids provide a more realistic and versatile model for studying cancers and cancer stem cells (CSCs). While fructose-bisphosphate aldolase C (ALDOC) has been identified in colorectal cancer spheroids, its role in GC has remained largely unexplored.

View Article and Find Full Text PDF

Gastric cancer (GC) is characterized by significant intratumoral heterogeneity, and stem cells are promising therapeutic targets. Despite advancements in spatial transcriptome analyses, unexplored targets for addressing cancer stemness remain unknown. This study aimed to identify Nuclear Factor IX (NFIX) as a critical regulator of cancer stemness in GC and evaluate its clinicopathological significance and function.

View Article and Find Full Text PDF

Introduction: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal types of malignancy, with poor prognosis and rising incidence. IQ motif containing GTPase-activating protein 3 (IQGAP3) is a member of the IQGAPs family of scaffolding proteins that govern multiple cellular activities like cytoskeletal remodeling and cellular signal transduction. This study aimed to analyze the expression and biological function of IQGAP3 in PDAC.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates KIF18B, a gene previously unreported in gastric cancer (GC), particularly in the context of gastric mucin phenotype GC, which is prevalent in Japan and associated with mortality.
  • - Analysis involved RNA sequencing and immunohistochemistry on 96 GC cases, revealing KIF18B expression in 54% of cases and its correlation with poor survival rates, as well as associations with other important molecules.
  • - Functional studies showed that silencing KIF18B in GC cells enhanced growth and altered the expression of key proteins involved in cell behavior, suggesting it could be a significant prognostic marker and contribute to understanding the cancer's development.
View Article and Find Full Text PDF

Background/aim: SEC11A gene encodes the SPC18 protein, which has been implicated in tumour progression by inducing the secretion of various growth factors. We investigated the clinical significance of SEC11A expression in gastric cancer (GC) tissues in patients with locally advanced gastric cancer (LAGC) after curative resection.

Patients And Methods: We estimated SEC11A expression in cancer tissues from 253 pStage II/III GC patients who underwent curative resection using quantitative polymerase chain reaction (PCR) and investigated the relationship of SEC11A expression with clinicopathological factors and survival.

View Article and Find Full Text PDF

Background: We sought to identify an optimal combination of survival risk stratification markers in patients with pathological (p) stage II/III gastric cancer (GC) after curative resection.

Methods: We measured the expression levels of 127 genes in pStage II/III GC tissues of two patient cohorts by quantitative polymerase chain reaction (qPCR) and the expression of 1756 proteins between two prognosis (good and poor) groups by proteomic analysis to identify candidate survival stratification markers. Further, immunohistochemistry (IHC) using tumor microarrays (TMAs) in another cohort of patients was performed to identify an optimal biomarker combination for survival stratification in GC patients.

View Article and Find Full Text PDF

Introduction: Gastric cancer (GC) is a leading cause of cancer-related death worldwide. This study focused on minichromosome maintenance 4 (MCM4), a DNA helicase component that functions in DNA replication. Using spheroid colony formation, having a colony rich in cancer stem cells, this study aimed to investigate the clinicopathological importance of MCM4.

View Article and Find Full Text PDF

Introduction: Tryptophan metabolism has been shown to be involved in tumor development. Two main tryptophan-degrading enzymes, tryptophan 2,3-dioxygenase (TDO2) and indoleamine 2,3-dioxygenase 1 (IDO1), may potently promote cancer cell survival and distant metastasis in diverse types of cancer, such as lung and breast cancer. IDO1 overexpression is an independent prognosticator in gastric cancer (GC).

View Article and Find Full Text PDF

Background: Genes encoding transmembrane proteins expressed specifically in cancer cells may be ideal therapeutic targets or biomarkers for diagnosis.

Methods: In the present study, we investigated the expression and function of PCDHB9, which encodes transmembrane protein protocadherin B9 in colorectal cancer (CRC).

Results: Immunohistochemical analysis showed that 39 (26%) of 148 CRC cases were positive for protocadherin B9.

View Article and Find Full Text PDF
Article Synopsis
  • Esophageal cancer is a major cause of cancer deaths globally, with a need for new targeted therapies, particularly for esophageal squamous cell cancer (ESCC), where the role of protocadherin (PCDH) B9 has been investigated.
  • In a study involving 128 cases, PCDHB9 was assessed via immunohistochemistry, with 31.3% of cases showing high expression, correlating with advanced disease features.
  • The research indicates that PCDHB9 not only promotes tumor growth but also alters the expression of various integrins and cadherins, making it a promising biomarker and potential target for ESCC treatment.
View Article and Find Full Text PDF

Background/aim: Gastric cancer (GC) is the third-leading cause of cancer-related deaths worldwide; thus, novel diagnostic and therapeutic biomarkers are needed. Annexin A10 (ANXA10) is a calcium- and phospholipid-binding protein. As far as we are aware, there are no reports describing the detailed functions of ANXA10 in GC.

View Article and Find Full Text PDF
Article Synopsis
  • Claspin is identified as a significant regulator in gastric and renal cancers, but its role in urothelial carcinoma (UC) had not been explored until now.
  • Analysis showed that claspin expression was weak or absent in normal urothelium, but present in 42% of UC cases, correlating with aggressive features like high tumor grade and invasiveness.
  • The presence of claspin is associated with poorer survival rates and may serve as both a new prognostic marker and a potential therapeutic target in urothelial carcinoma.
View Article and Find Full Text PDF

The utility of Schlafen 11 (SLFN11) expression as a predictive biomarker for platinum-based chemotherapy has been established for cancers from different histologies. However, the therapeutic relevance of SLFN11 in bladder cancer (BC) is unknown. Here, we examined the clinicopathologic significance of SLFN11 expression across 120 BC cases by immunohistochemistry.

View Article and Find Full Text PDF

Kinesin family member C1 (), a minus end-directed motor protein, is reported to play an essential role in cancer. This study aimed to analyze expression and examine involvement in cisplatin resistance in bladder cancer (BC). Immunohistochemistry showed that 37 of 78 (47.

View Article and Find Full Text PDF

Homeobox genes function as master regulatory transcription factors during embryogenesis. HOXB5 is known to play an important role in several cancers. However, the biological role of HOXB5 in prostate cancer (PCa) is not fully elucidated.

View Article and Find Full Text PDF

Background: The attainment of drug resistance in gastric cancer (GC) is a problematic issue. Although many studies have shown that cancer stem cells (CSCs) play an important role in the acquisition of drug resistance, there is no clinically available biomarker for predicting oxaliplatin (L-OHP) resistance in relation to CSCs. Organoid technology, a novel 3D cell culture system, allows harboring of patient-derived cancer cells containing abundant CSCs using niche factors in a dish.

View Article and Find Full Text PDF

To detect muscle-invasive upper tract urothelial carcinoma, we evaluated the internal texture of the tumor using texture analysis of computed tomography images in 86 cases of upper tract urothelial carcinoma. The internal texture of the tumor was evaluated as the value of computed tomography attenuation number of the unenhanced image, and the median, standard deviation, skewness and kurtosis were calculated. Each parameter was compared with clinicopathological factors, and their associations with postoperative prognosis were investigated.

View Article and Find Full Text PDF

Although docetaxel (DTX) confers significant survival benefits in patients with castration-resistant prostate cancer (CRPC), resistance to DTX inevitably occurs. Therefore, clarifying the mechanisms of DTX resistance may improve survival in patients with CRPC. Claspin plays a pivotal role in DNA replication stress and damage responses and is an essential regulator for the S-phase checkpoint.

View Article and Find Full Text PDF

Objective: To evaluate the clinical benefit of tumor contact length as a predictor of pathological extraprostatic extension and biochemical recurrence in patients undergoing prostatectomy.

Methods: A total of 91 patients who underwent 3T multiparametric magnetic resonance imaging before prostatectomy from April 2014 to July 2019 were included. A total of 94 prostate cancer foci were analyzed retrospectively.

View Article and Find Full Text PDF

Physicians can prolongedly use expanded polytetrafluoroethylene sheets for fixation of artificial cardiac pacemakers to avoid pacemaker lead displacement. The sheets can also be used to prevent implant rejection in patients with metal allergies.

View Article and Find Full Text PDF

Background: Tryptophan 2,3-dioxygenase (TDO2) is the primary enzyme catabolizing tryptophan. Several lines of evidence revealed that overexpression of TDO2 is involved in anoikis resistance, spheroid formation, proliferation, and invasion and correlates with poor prognosis in some cancers. The aim of this research was to uncover the expression and biofunction of TDO2 in renal cell carcinoma (RCC).

View Article and Find Full Text PDF

Background: Bladder cancer (BC) is the 10th most common cancer in the world. BC with muscle invasion results in a poor prognosis and is usually fatal. Cancer cell metabolism has an essential role in the development and progression of tumors.

View Article and Find Full Text PDF
Article Synopsis
  • Tumor budding (TB) is identified as a negative prognostic marker in colorectal cancer (CRC), but its significance in patients undergoing drug therapy remains underexplored.
  • A study involving 237 stage III CRC patients evaluated the impact of TB on disease-free survival (DFS) after adjuvant chemotherapy, revealing that those with low TB (fewer than 5 buds) had significantly better DFS outcomes.
  • The findings suggest that TB may help identify stage III CRC patients who can expect a more favorable prognosis when treated with 5-fluorouracil (5-FU) monotherapy.
View Article and Find Full Text PDF

Colorectal cancer (CRC) is the second leading cause of cancer-related mortality worldwide. Kinesin Family Member C1 (KIFC1) has been proposed as a promising therapeutic target due to its pivotal role in centrosome clustering to mediate cancer cell progression. This study aimed to analyze the expression and biological function of KIFC1 in CRC.

View Article and Find Full Text PDF

Background/aim: Small bowel adenocarcinoma (SBA) is a relatively rare malignant epithelial neoplasm. Thus, little is known about prognostic biomarkers of SBA. Annexin A10 (ANXA10) is a member of the annexin family.

View Article and Find Full Text PDF